13:30
Next-generation co-stimulation blockade
Cheng Yang (CN)
Programme
Browse the programme by date and add sessions or individual talks to My Agenda.
Filter programme · 1 active
Monday, September 21, 2026
Cockle Bay 1
Precision Immune Engineering in Kidney Transplantation
Precision Immune Engineering in Kidney Transplantation
Chairs
Fadi Issa (GB) · Stephen Alexander (AU)
Presentations
13:30
13:52
Regulatory T-cell therapy 2.0: CAR-Tregs
Megan Levings (CA)
14:14
Emerging pharmacotherapies for desensitization in HLA incompatible kidney transplantation
Marta Crespo Barrio (ES)
14:36
How immunosuppressed is my patient: the role of biomarkers in immunosuppression adjustment
Philip O'Connell (AU)
Cockle Bay 2
Bridging Systems, Scaling Access: Asia-Pacific Leadership in Transplantation
Bridging Systems, Scaling Access: Asia-Pacific Leadership in Transplantation
Chairs
Anis Ta'eed (FJ) · Anil Kumar (IN)
Presentations
13:30
From intent to impact: How to start and sustain a deceased donation programme
Maria Gomez (AE)
13:47
Equity and access in fragile health systems: A south asian perspective
Dibya Singh Shah (NP)
14:04
Paired kidney donation at scale: Asian experience driving global dialogue
Pranjal Kashiv (IN)
14:21
From data to action: Asian models of registry-driven transplant policy reform
Jong Cheol Jeong (KR)
14:38
The role of international collaboration in developing transplant programs: A success story from TTS-ILTS paired transplant centers program
Sergelen Orgoi (MN)
Room C3.3
Senotherapy in transplantation
Senotherapy in transplantation
Chairs
Krista Lentine (US) · Jasper Iske (DE)
Presentations
13:30
Aged immune systems drives organ aging
Matthew Yousefzadeh (US)
13:52
Global and local consequences of ‘environmental sciences’ on organ age
Stefan Tullius (US)
14:14
Cell-type and sex specific aspects of senescence
Anette Melk (DE)
14:36
Strategies for senolytic drug discovery
Aaron Schindeler (AU)
Room C3.4-C3.5
How to combat transplant tourism
How to combat transplant tourism
Chairs
Thomas F. Müller (CH) · Benita Padilla (PH)
Presentations
13:30
Patients traveling overseas for transplants - Practical experiences
Anantharaman Vathsala (SG)
13:40
Challenges in registering unethical travel for transplant activities
Dominique Martin (AU)
13:50
The living donor liver registry
Dimitri A. Raptis (SA)
14:00
Tools to detect and report suspicious cases of trafficking
Maria Amalia Matamoros (CR)
14:15
Duty to report – The implementation of mandatory reporting: The UK experience so far
Jessica Porter (GB)
14:30
Panel Discussion
Discussion Period (AU)
Room C3.6
Bridging Transplantation and Regenerative Medicine: Enhancing Graft Viability and Exploring Stem Cell-Islet Immunotherapies in Diabetes
Bridging Transplantation and Regenerative Medicine: Enhancing Graft Viability and Exploring Stem Cell-Islet Immunotherapies in Diabetes
Chairs
Wayne J. Hawthorne (AU) · Thomas Kay (AU)
Presentations
13:30
Pancreas transplantation in type 2 diabetes mellitus
Peter G. Stock (US)
13:47
Diagnosis and treatment of pancreas rejection
Pablo Uva (AR)
14:04
Islets and stem cells in diabetes therapy: Current status
Eelco de Koning (NL)
14:21
Enhancing outcomes with innovative immunosuppressive therapies: Strategies and challenges
Toby Coates (AU)
14:38
Towards immunosuppression-free transplantation: Stem cell-based approaches and immune tolerance
Hanne Scholz (NO)
Room C4.4
Minimal Invasive Transplantation
Minimal Invasive Transplantation
Chairs
Susumu Eguchi (JP) · Emily Granger (AU)
Presentations
13:30
Minimally invasive thoracic organ transplantation
Albert Jauregui (ES)
13:52
Minimally invasive abdominal organ transplantation
Kwang Woong Lee (KR)
14:14
Education and training strategies to safely disseminate robotic organ transplantation
Jinna Yao (AU)
14:36
Future technological development in robotic organ transplantation
Dieter Broering (SA)
Room C4.5
Using Technology to optimize outcomes of Liver Transplantation
Using Technology to optimize outcomes of Liver Transplantation
Presentations
13:30
Normothermic regional perfusion: Is ex vivo perfusion still necessary?
Anji Wall (US)
13:52
What does optimal use of HOPE and NMP look like?
Carlo Pulitano (AU)
14:14
Ischemia-free organ transplantation
Zhiyong Guo (CN)
14:36
The future for artificial Intelligence in liver transplant
Dorry Segev (US)
Room C4.6
Advancing Uterus Transplantation: Global Practices, Innovations, and Program Development
Advancing Uterus Transplantation: Global Practices, Innovations, and Program Development
Chairs
Jiri Fronek (CZ) · Limor Meoded Danon (IL)
Presentations
13:30
Global uterus transplantation activities and outcomes: the ISUTx registry
Mats Brännström (SE)
13:52
Robotic surgery in uterus transplantation
Jean-Marc Ayoubi (FR)
14:14
Setting up a uterus transplantation program
Rebecca Deans (AU)
14:36
Updates on treatment and donor/recipient selection
Paige Porrett (US)
Room C4.7
Innovating the Pathway: Allied Health Contributions to Advancing Organ Donation and Transplantation
Innovating the Pathway: Allied Health Contributions to Advancing Organ Donation and Transplantation
Chairs
Anne Floden (SE) · Bronwyn Levvey (AU)
Presentations
13:30
Driving excellence in transplant care: The role, vision and impact of the tts allied health committee
Estephan Arredondo (ES)
13:45
Extending organ viability: The role of allied health in machine perfusion programs
Joaquim Albiol (ES)
14:00
Mobilizing recovery: Physiotherapy as a key player in the transplant continuum
Louise Fuller (AU)
14:15
Strategies to improve adherence after solid organ transplantation
Mariel Nöhre (DE)
14:30
Panel Discussion
Discussion Period (AU)
Panel discussion
Bronwyn Levvey (AU)
Room C4.8
Donor Evaluation and Optimization: Bridging Safety and Organ Utilization
Donor Evaluation and Optimization: Bridging Safety and Organ Utilization
Chairs
Tina Marinelli (AU) · Atul Humar (CA)
Presentations
13:30
mNGS and rapid diagnostics: The next frontier in donor screening?
Maricar Malinis (US)
13:52
HIV-positive organ donation: Evolving guidelines and global perspectives
Cameron R. Wolfe (US)
14:14
MDRO: Cross-disciplinary approaches to donor-derived infection risk assessment
Priscilla Rupali (IN)
14:36
Donors in the tropics and LMICs: What to consider?
Siriorn Watcharananan (TH)
Room C4.11
Harnessing the Power of Genetics in Pediatric Transplantation
Harnessing the Power of Genetics in Pediatric Transplantation
Chairs
Siah Kim (AU) · Carl Grabitz (DE)
Presentations
13:30
Overview of genomic sequencing techniques
Katherine E. Twombley (US)
14:00
When and why to consider genetic testing pre-transplant
Hugh McCarthy (AU)
14:30
Bioethics in transplant gene testing
Anne Priesz (AU)
Room C4.4
From patient to planet: The global essential standards as a framework for transformative change in transplantation
From patient to planet: The global essential standards as a framework for transformative change in transplantation
Chair
John J. Fung (US)
Presentations
15:30
The human face of standards
John J. Fung (US)
15:35
From principles to practice: Protecting dignity, trust and equity in transplantation
John J. Fung (US)
Nothing about us without us: Making patients and families partners in transplantation
Karen Rockell (GB)
16:00
The institutional blueprint: How the global essential standards create a transplant ecosystem that is equitable, safe, and self-sustaining
Medhat Askar (US)
16:25
Stakeholders perspective from China: Translating standards into value for every actor in the ecosystem
Haibo Wang (CN)
16:35
Stakeholders perspective from Australia: Translating standards into value for every actor in the ecosystem
Helen Opdam (AU)
16:45
Connecting the circles: Panel discussions
Discussion Period (AU)
Tuesday, September 22, 2026
Cockle Bay 2
Targeting immune cell metabolism to control alloimmunity
Targeting immune cell metabolism to control alloimmunity
Presentations
13:30
How T cell metabolism regulates function and survival
Carl Atkinson (US)
13:50
Treg metabolism and the impact of metabolites on their function and disease progression
Ling Lyu (CN)
14:10
Targeting Innate Immunometabolism in Organ Transplantation
Yohana Toner (NL)
14:30
T cell landscapes following hematopoietic stem cell transplantation
Antiopi Varelias (AU)
Room C3.3
Redefining Surgical Excellence: Metrics, Equity, and Global Perspectives
Redefining Surgical Excellence: Metrics, Equity, and Global Perspectives
Chairs
Animesh Singla (AU) · Peter G. Stock (US)
Presentations
13:30
Driving quality improvement through global surgical registries
Dimitri A. Raptis (SA)
13:50
Novel outcome metrics in surgery: Beyond survival to value-based excellence
Yolanda Becker (US)
14:10
Ensuring diversity in the transplant surgery workforce
Kendra Conzen (US)
14:30
Beyond steatosis: The multisystem metabolic nature of fatty liver disease and its impact on surgical outcomes
Nazia Selzner (CA)
Room C3.4-C3.5
Deceased Donation Research: Findings and Future Directions
Deceased Donation Research: Findings and Future Directions
Chair
Dominique Martin (AU)
Presentations
13:30
Donor intervention studies – ethical and practical challenges
Dale Gardiner (GB)
13:40
Deceased donor physiological management research
Gary F. Marklin (US)
13:50
Thoracic ex-situ machine perfusion research
Sarah Scheuer (AU)
14:00
Biobanks for research
Claire Gordon (AU)
14:10
Panel Discussion
Discussion Period (AU)
Room C3.6
Pluripotent stem cells and regenerative medicine: the future of transplantation?
Pluripotent stem cells and regenerative medicine: the future of transplantation?
Chair
Edward Geissler (DE)
Presentations
13:30
Developing an engineered heart tissue patch for heart failure.
Enzo Porrello (AU)
13:50
Pluripotent stem cells: Where are we in building new lungs?
Rhiannon Werder (AU)
14:10
Tissue engineering and regenerative medicine: Perspectives on recent developments and directions
Anthony Weiss (AU)
14:30
Stem cell derived islets under abdominal anterior rectus sheath in a type 1 diabetes patient
Shusen Wang (CN)
Room C4.1
Biology and beyond: Multiple dimensions of transplantation
Biology and beyond: Multiple dimensions of transplantation
Presentations
13:30
Addressing gender disparity in access to pediatric kidney transplantation in India
Kinnari Vala (IN)
13:50
Social and cultural conflicts in uterine transplantation
Limor Meoded Danon (IL)
14:10
Impact of sex on cardiovascular outcomes after pediatric kidney transplantation
Rizky Indrameikha Sugianto (DE)
14:30
Intersection of sex/gender, and cancer after transplantation
Brenda Maria Rosales (AU)
Room C4.4
Transplanting Against the Antibody Odds
Transplanting Against the Antibody Odds
Chairs
Ankit Sharma (AU) · Anne Halpin (CA)
Presentations
13:30
Overview of new HLA tools for measuring antibodies and rapid high resolution sequencing
Sandra Tafulo (PT)
13:50
Crossing DSA in lung transplant: Is necessity the mother of invention?
Kieran Halloran (CA)
14:10
Immune memory responses: Unmasking the hidden antibody potential
Gonca E. Karahan (NL)
14:30
Organ allocation strategies for HLA compatibility
Philip Andrew Clayton (AU)
Room C4.6
Honouring voices, changing systems: Indigenous leadership in transplant equity
Honouring voices, changing systems: Indigenous leadership in transplant equity
Presentations
13:30
Indigenous peoples and organ donation and transplantation in Canada: Improving access to care
Aviva Goldberg (CA)
13:50
Ka whawhai tonu, ka haere ake: Fighting to advance transplant equity in Aotearoa New Zealand
Curtis Walker (NZ)
14:10
Wangkanthi purdita purruna naalitya - Talking kidney health for you Mob
Kelli Owen (AU)
Co-Presenting: Wangkanthi Purdita Purruna Naalitya - Talking Kidney Health for you Mob
Stephen McDonald (AU)
14:30
Panel Discussion and Q&A
Discussion Period (AU)
Room C4.7
Artificial intelligence (AI) in Transplant Education
Artificial intelligence (AI) in Transplant Education
Presentations
13:30
From concept to classroom: How to start using AI in transplant education?
Susu Zughaier (QA)
13:50
Mixed reality technology in organ transplantation
Alfred Kow (SG)
14:10
AI in Transplantation: AI capabilities, applications and responsible use
Bill Simpson-Young (AU)
14:30
Panel Discussion
Discussion Period (AU)
Panelist
Ala Ali (IQ)
Room C4.9
Transplant Oncology: Peering Over the Horizon
Transplant Oncology: Peering Over the Horizon
Chairs
Kwang Woong Lee (KR) · Mohamed Rela (IN)
Presentations
13:30
Liver transplantation for unresectable hilar cholangiocarcinoma: Who truly benefits?
Julie K. Heimbach (US)
13:47
Neuroendocrine tumours and liver transplantation: Time to move beyond traditional boundaries?
Takashi Ito (JP)
14:04
Intrahepatic cholangiocarcinoma and liver transplantation: Pushing the limits of what’s surgically and biologically possible
Sudha Kodali (US)
14:21
Liver transplantation for hepatoblastoma: Does biology drive the decision to transplant?
Mohamed Rela (IN)
14:38
Liver transplantation for non-hepatoblastoma paediatric tumours: LT as a curative tool?
Seisuke Sakamoto (JP)
Room C4.11
Obesity Management in Transplantation: Current Evidence and Practical Approaches
Obesity Management in Transplantation: Current Evidence and Practical Approaches
Chairs
Dorry Segev (US) · Marina Berenguer (ES)
Presentations
13:30
Latest evidence on GLP-1s in transplantation
Babak Orandi (US)
13:50
Managing obesity without GLP-1s: Alternative strategies
Amanda Velazquez (US)
14:10
Bariatric surgery in transplantation: Opportunities and challenges
Shashank R. Joshi (IN)
14:30
Facilitating weight loss in individuals with frailty and sarcopenia
Astrid Ruiz-Margáin (MX)
Wednesday, September 23, 2026
Cockle Bay 1
Clinical Xenotransplantation has Arrived!
Clinical Xenotransplantation has Arrived!
Presentations
13:45
Understanding optimal genetic modification
Peter Cowan (AU)
14:05
Experience and immunosuppression for clinical xenotransplantation
Muhammad Mohiuddin (US)
14:25
Special challenges of lung xenotransplantation
Richard N. Pierson (US)
14:45
Clinical xenotransplantation: A new era through the eyes of patients and families
Macey L. Levan (US)
Cockle Bay 2
Living Organ Donation in 2026: Unified Principles, Organ-Specific Nuances
Living Organ Donation in 2026: Unified Principles, Organ-Specific Nuances
Chairs
Kwang Woong Lee (KR) · Henry Pleass (AU)
Presentations
13:45
Shared framework for living donor evaluation: medical, psychosocial, and ethical core
Krista Lentine (US)
14:05
Surgical challenges and functional outcomes in living kidney donation
Mireia Musquera (ES)
14:25
Surgical challenges and functional outcomes in living liver donation
Dong Jin Joo (KR)
14:45
Predictive models and global registry insights to enhance donor safety
Allan Massie (US)
Room C3.3
Targeted Therapies and Tailored Dosing: The New Era in ABMR Treatment
Targeted Therapies and Tailored Dosing: The New Era in ABMR Treatment
Chairs
Jen Li (AU) · Lori J. West (CA)
Presentations
13:45
Is there still a role for anti IL-6R in ABMR treatment?
Roslyn B. Mannon (US)
14:05
Is anti-CD38 the most promising agent for ABMR?
Katharina Mayer (AT)
14:25
What does monitoring AUC add compared to C-trough only?
Teun van Gelder (NL)
14:45
Model Informed precision dosing
Anders Asberg (NO)
Room C3.6
Diversity, Equity, and Inclusion in Gender and Transplantation
Diversity, Equity, and Inclusion in Gender and Transplantation
Chairs
Maria Gomez (AE) · Anette Melk (DE)
Presentations
13:45
Regional and gender disparities in abstracts presented at international transplant congress
Maggie Kam Man Ma (HK)
14:05
Unseen and unequal: Addressing gender and financial disparities in access to kidney transplantation
Nicole Jane Scholes-Robertson (AU)
14:25
Redefining equity: Women, access, and outcomes in liver transplantation
Gomathy Narasimhan (IN)
14:45
Designing gender-responsive transplant policies: Lessons from south and southeast Asia
Chandana Guha (AU)
Room C4.1
Evolving Ethics and Emerging Trends in Transplantation
Evolving Ethics and Emerging Trends in Transplantation
Chairs
David Thomson (ZA) · Aviva Goldberg (CA)
Presentations
13:45
Rating ourselves on the ethics of NRP - How are we doing?
Anji Wall (US)
14:05
Social media use in transplantation
Shaifali Sandal (CA)
14:25
Pediatric prioritization
Thozama Siyotula (ZA)
14:45
Retransplantation after nonadherence (adult & children)
Aaron Wightman (US)
Room C4.5
Innovations in skin cancer in transplantation
Innovations in skin cancer in transplantation
Presentations
13:45
Skin cancer risk prediction and communication
Anne Cust (AU)
14:03
Evaluation of benefits and harms of melanoma screening in chronic disease
Katy Bell (AU)
14:21
Complex surgical oncology
Alexander Varey (AU)
14:39
Novel developments in keratinocyte cancer treatments in Australia
Kiarash Khosrotehrani (AU)
14:57
Panel Discussion
Discussion Period (AU)
Room C4.6
Rise of the Machines: Maximizing donor opportunities in Thoracic Transplantation
Rise of the Machines: Maximizing donor opportunities in Thoracic Transplantation
Chairs
Miranda Paraskeva (AU) · Pablo Sanchez (US)
Presentations
13:45
Debate 1: Pro rapid recovery/no-reanimation for thoracic transplantation
Aaron M. Williams (US)
13:57
Debate 1: Pro ex vivo machine perfusion
Peter MacDonald (AU)
14:09
Debate 2: Pro ex vivo perfusion
Sandra Lindstedt (SE)
14:21
Debate 2: Pro immediate transplant
Gregory I. Snell (AU)
14:33
Expanding the donor pool: Practical implementation of normothermic regional perfusion for DCD heart and lung recovery
Irene Bello (ES)
14:48
Panel Discussion
Discussion Period (AU)
Room C4.7
State of VCA- Present and Future
State of VCA- Present and Future
Chairs
Patrik Lassus (FI) · Hatem Amer (US)
Presentations
13:45
Overview of VCA transplants
Hatem Amer (US)
14:03
VCA becoming part of universal health care
David Leonard (GB)
14:21
Is VCA reconstructive surgery or transplantation
Linda C. Cendales (US)
14:39
Challenges and opportunities for VCA in the global south
Subramania Iyer (IN)
14:57
Standardizing outcomes in VCA: Are we ready for a SONG or for COVER
Allison Jaure (AU)
Room C4.8
Next-Generation Transplantation: Regenerative Medicine Breakthroughs
Next-Generation Transplantation: Regenerative Medicine Breakthroughs
Chairs
Giuseppe Orlando (US) · Vijay Gorantla (US)
Presentations
13:45
The bioartificial kidney: Lessons learned and the road ahead
William Fissell (CA)
14:10
Organoids, organs-on-a-chip, and the path to organ manufacturing
Sean Vincent Murphy (US)
14:35
Engineering vision: Whole-eye transplantation, bioengineering and regeneration
Vijay Gorantla (US)
14:55
Regenerative transplantation: Transforming organ replacement through regenerative medicine
Giuseppe Orlando (US)
Room C4.9
Evolving strategies in intestinal and multivisceral transplantation
Evolving strategies in intestinal and multivisceral transplantation
Chairs
Helen Evans (NZ) · Rajith Amaratunga (AU)
Presentations
13:45
Isolated intestine transplantation for short gut syndrome in the era of GLP-2 agonist
Yaron Avitzur (CA)
14:05
Novel immunosuppression in intestine transplantation
Jennifer Garcia (US)
14:25
Pros and cons of protocol biopsy and stoma
Jonathan Hind (AU)
14:45
Multivisceral transplantation: Patient selection, surgical challenges, and outcomes
Graham Starkey (AU)